Request for Covid-19 Impact Assessment of this Report
The United States Anti-Emetic Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Anti-Emetic Drug market, reaching US$ million by the year 2028. As for the Europe Anti-Emetic Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Anti-Emetic Drug players cover Merck, Novartis, Glenmark Pharmaceuticals, and F. Hoffmann-La Roche, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Emetic Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Oral
Injection
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Home Care
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck
Novartis
Glenmark Pharmaceuticals
F. Hoffmann-La Roche
Heron Therapeutics
Kyowa Kirin
Aurobindo Pharma
Mylan
Hikma
Akorn
Dr. Reddy’s Laboratories
Cipla
Fresenius Kabi
Wockhardt
Sun Pharmaceutical Industries
Teva Pharmaceutical
Pfizer
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-Emetic Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Anti-Emetic Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Anti-Emetic Drug by Country/Region, 2017, 2022 & 2028
2.2 Anti-Emetic Drug Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 Others
2.3 Anti-Emetic Drug Sales by Type
2.3.1 Global Anti-Emetic Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Anti-Emetic Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Anti-Emetic Drug Sale Price by Type (2017-2022)
2.4 Anti-Emetic Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Home Care
2.4.4 Others
2.5 Anti-Emetic Drug Sales by Application
2.5.1 Global Anti-Emetic Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Anti-Emetic Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Anti-Emetic Drug Sale Price by Application (2017-2022)
3 Global Anti-Emetic Drug by Company
3.1 Global Anti-Emetic Drug Breakdown Data by Company
3.1.1 Global Anti-Emetic Drug Annual Sales by Company (2020-2022)
3.1.2 Global Anti-Emetic Drug Sales Market Share by Company (2020-2022)
3.2 Global Anti-Emetic Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Anti-Emetic Drug Revenue by Company (2020-2022)
3.2.2 Global Anti-Emetic Drug Revenue Market Share by Company (2020-2022)
3.3 Global Anti-Emetic Drug Sale Price by Company
3.4 Key Manufacturers Anti-Emetic Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Emetic Drug Product Location Distribution
3.4.2 Players Anti-Emetic Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Anti-Emetic Drug by Geographic Region
4.1 World Historic Anti-Emetic Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Anti-Emetic Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Anti-Emetic Drug Annual Revenue by Geographic Region
4.2 World Historic Anti-Emetic Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Anti-Emetic Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Anti-Emetic Drug Annual Revenue by Country/Region
4.3 Americas Anti-Emetic Drug Sales Growth
4.4 APAC Anti-Emetic Drug Sales Growth
4.5 Europe Anti-Emetic Drug Sales Growth
4.6 Middle East & Africa Anti-Emetic Drug Sales Growth
5 Americas
5.1 Americas Anti-Emetic Drug Sales by Country
5.1.1 Americas Anti-Emetic Drug Sales by Country (2017-2022)
5.1.2 Americas Anti-Emetic Drug Revenue by Country (2017-2022)
5.2 Americas Anti-Emetic Drug Sales by Type
5.3 Americas Anti-Emetic Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Emetic Drug Sales by Region
6.1.1 APAC Anti-Emetic Drug Sales by Region (2017-2022)
6.1.2 APAC Anti-Emetic Drug Revenue by Region (2017-2022)
6.2 APAC Anti-Emetic Drug Sales by Type
6.3 APAC Anti-Emetic Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Anti-Emetic Drug by Country
7.1.1 Europe Anti-Emetic Drug Sales by Country (2017-2022)
7.1.2 Europe Anti-Emetic Drug Revenue by Country (2017-2022)
7.2 Europe Anti-Emetic Drug Sales by Type
7.3 Europe Anti-Emetic Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti-Emetic Drug by Country
8.1.1 Middle East & Africa Anti-Emetic Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Anti-Emetic Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Anti-Emetic Drug Sales by Type
8.3 Middle East & Africa Anti-Emetic Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Emetic Drug
10.3 Manufacturing Process Analysis of Anti-Emetic Drug
10.4 Industry Chain Structure of Anti-Emetic Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Emetic Drug Distributors
11.3 Anti-Emetic Drug Customer
12 World Forecast Review for Anti-Emetic Drug by Geographic Region
12.1 Global Anti-Emetic Drug Market Size Forecast by Region
12.1.1 Global Anti-Emetic Drug Forecast by Region (2023-2028)
12.1.2 Global Anti-Emetic Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-Emetic Drug Forecast by Type
12.7 Global Anti-Emetic Drug Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Anti-Emetic Drug Product Offered
13.1.3 Merck Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Anti-Emetic Drug Product Offered
13.2.3 Novartis Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Glenmark Pharmaceuticals
13.3.1 Glenmark Pharmaceuticals Company Information
13.3.2 Glenmark Pharmaceuticals Anti-Emetic Drug Product Offered
13.3.3 Glenmark Pharmaceuticals Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Glenmark Pharmaceuticals Main Business Overview
13.3.5 Glenmark Pharmaceuticals Latest Developments
13.4 F. Hoffmann-La Roche
13.4.1 F. Hoffmann-La Roche Company Information
13.4.2 F. Hoffmann-La Roche Anti-Emetic Drug Product Offered
13.4.3 F. Hoffmann-La Roche Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 F. Hoffmann-La Roche Main Business Overview
13.4.5 F. Hoffmann-La Roche Latest Developments
13.5 Heron Therapeutics
13.5.1 Heron Therapeutics Company Information
13.5.2 Heron Therapeutics Anti-Emetic Drug Product Offered
13.5.3 Heron Therapeutics Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Heron Therapeutics Main Business Overview
13.5.5 Heron Therapeutics Latest Developments
13.6 Kyowa Kirin
13.6.1 Kyowa Kirin Company Information
13.6.2 Kyowa Kirin Anti-Emetic Drug Product Offered
13.6.3 Kyowa Kirin Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Kyowa Kirin Main Business Overview
13.6.5 Kyowa Kirin Latest Developments
13.7 Aurobindo Pharma
13.7.1 Aurobindo Pharma Company Information
13.7.2 Aurobindo Pharma Anti-Emetic Drug Product Offered
13.7.3 Aurobindo Pharma Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Aurobindo Pharma Main Business Overview
13.7.5 Aurobindo Pharma Latest Developments
13.8 Mylan
13.8.1 Mylan Company Information
13.8.2 Mylan Anti-Emetic Drug Product Offered
13.8.3 Mylan Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Mylan Main Business Overview
13.8.5 Mylan Latest Developments
13.9 Hikma
13.9.1 Hikma Company Information
13.9.2 Hikma Anti-Emetic Drug Product Offered
13.9.3 Hikma Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Hikma Main Business Overview
13.9.5 Hikma Latest Developments
13.10 Akorn
13.10.1 Akorn Company Information
13.10.2 Akorn Anti-Emetic Drug Product Offered
13.10.3 Akorn Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Akorn Main Business Overview
13.10.5 Akorn Latest Developments
13.11 Dr. Reddy’s Laboratories
13.11.1 Dr. Reddy’s Laboratories Company Information
13.11.2 Dr. Reddy’s Laboratories Anti-Emetic Drug Product Offered
13.11.3 Dr. Reddy’s Laboratories Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Dr. Reddy’s Laboratories Main Business Overview
13.11.5 Dr. Reddy’s Laboratories Latest Developments
13.12 Cipla
13.12.1 Cipla Company Information
13.12.2 Cipla Anti-Emetic Drug Product Offered
13.12.3 Cipla Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Cipla Main Business Overview
13.12.5 Cipla Latest Developments
13.13 Fresenius Kabi
13.13.1 Fresenius Kabi Company Information
13.13.2 Fresenius Kabi Anti-Emetic Drug Product Offered
13.13.3 Fresenius Kabi Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Fresenius Kabi Main Business Overview
13.13.5 Fresenius Kabi Latest Developments
13.14 Wockhardt
13.14.1 Wockhardt Company Information
13.14.2 Wockhardt Anti-Emetic Drug Product Offered
13.14.3 Wockhardt Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Wockhardt Main Business Overview
13.14.5 Wockhardt Latest Developments
13.15 Sun Pharmaceutical Industries
13.15.1 Sun Pharmaceutical Industries Company Information
13.15.2 Sun Pharmaceutical Industries Anti-Emetic Drug Product Offered
13.15.3 Sun Pharmaceutical Industries Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Sun Pharmaceutical Industries Main Business Overview
13.15.5 Sun Pharmaceutical Industries Latest Developments
13.16 Teva Pharmaceutical
13.16.1 Teva Pharmaceutical Company Information
13.16.2 Teva Pharmaceutical Anti-Emetic Drug Product Offered
13.16.3 Teva Pharmaceutical Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Teva Pharmaceutical Main Business Overview
13.16.5 Teva Pharmaceutical Latest Developments
13.17 Pfizer
13.17.1 Pfizer Company Information
13.17.2 Pfizer Anti-Emetic Drug Product Offered
13.17.3 Pfizer Anti-Emetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Pfizer Main Business Overview
13.17.5 Pfizer Latest Developments
14 Research Findings and Conclusion
Table 1. Anti-Emetic Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Anti-Emetic Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injection
Table 5. Major Players of Others
Table 6. Global Anti-Emetic Drug Sales by Type (2017-2022) & (K Units)
Table 7. Global Anti-Emetic Drug Sales Market Share by Type (2017-2022)
Table 8. Global Anti-Emetic Drug Revenue by Type (2017-2022) & ($ million)
Table 9. Global Anti-Emetic Drug Revenue Market Share by Type (2017-2022)
Table 10. Global Anti-Emetic Drug Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Anti-Emetic Drug Sales by Application (2017-2022) & (K Units)
Table 12. Global Anti-Emetic Drug Sales Market Share by Application (2017-2022)
Table 13. Global Anti-Emetic Drug Revenue by Application (2017-2022)
Table 14. Global Anti-Emetic Drug Revenue Market Share by Application (2017-2022)
Table 15. Global Anti-Emetic Drug Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Anti-Emetic Drug Sales by Company (2020-2022) & (K Units)
Table 17. Global Anti-Emetic Drug Sales Market Share by Company (2020-2022)
Table 18. Global Anti-Emetic Drug Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Anti-Emetic Drug Revenue Market Share by Company (2020-2022)
Table 20. Global Anti-Emetic Drug Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Anti-Emetic Drug Producing Area Distribution and Sales Area
Table 22. Players Anti-Emetic Drug Products Offered
Table 23. Anti-Emetic Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Anti-Emetic Drug Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Anti-Emetic Drug Sales Market Share Geographic Region (2017-2022)
Table 28. Global Anti-Emetic Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Anti-Emetic Drug Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Anti-Emetic Drug Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Anti-Emetic Drug Sales Market Share by Country/Region (2017-2022)
Table 32. Global Anti-Emetic Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Anti-Emetic Drug Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Anti-Emetic Drug Sales by Country (2017-2022) & (K Units)
Table 35. Americas Anti-Emetic Drug Sales Market Share by Country (2017-2022)
Table 36. Americas Anti-Emetic Drug Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Anti-Emetic Drug Revenue Market Share by Country (2017-2022)
Table 38. Americas Anti-Emetic Drug Sales by Type (2017-2022) & (K Units)
Table 39. Americas Anti-Emetic Drug Sales Market Share by Type (2017-2022)
Table 40. Americas Anti-Emetic Drug Sales by Application (2017-2022) & (K Units)
Table 41. Americas Anti-Emetic Drug Sales Market Share by Application (2017-2022)
Table 42. APAC Anti-Emetic Drug Sales by Region (2017-2022) & (K Units)
Table 43. APAC Anti-Emetic Drug Sales Market Share by Region (2017-2022)
Table 44. APAC Anti-Emetic Drug Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Anti-Emetic Drug Revenue Market Share by Region (2017-2022)
Table 46. APAC Anti-Emetic Drug Sales by Type (2017-2022) & (K Units)
Table 47. APAC Anti-Emetic Drug Sales Market Share by Type (2017-2022)
Table 48. APAC Anti-Emetic Drug Sales by Application (2017-2022) & (K Units)
Table 49. APAC Anti-Emetic Drug Sales Market Share by Application (2017-2022)
Table 50. Europe Anti-Emetic Drug Sales by Country (2017-2022) & (K Units)
Table 51. Europe Anti-Emetic Drug Sales Market Share by Country (2017-2022)
Table 52. Europe Anti-Emetic Drug Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Anti-Emetic Drug Revenue Market Share by Country (2017-2022)
Table 54. Europe Anti-Emetic Drug Sales by Type (2017-2022) & (K Units)
Table 55. Europe Anti-Emetic Drug Sales Market Share by Type (2017-2022)
Table 56. Europe Anti-Emetic Drug Sales by Application (2017-2022) & (K Units)
Table 57. Europe Anti-Emetic Drug Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Anti-Emetic Drug Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Anti-Emetic Drug Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Anti-Emetic Drug Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Anti-Emetic Drug Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Anti-Emetic Drug Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Anti-Emetic Drug Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Anti-Emetic Drug Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Anti-Emetic Drug Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Anti-Emetic Drug
Table 67. Key Market Challenges & Risks of Anti-Emetic Drug
Table 68. Key Industry Trends of Anti-Emetic Drug
Table 69. Anti-Emetic Drug Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Anti-Emetic Drug Distributors List
Table 72. Anti-Emetic Drug Customer List
Table 73. Global Anti-Emetic Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Anti-Emetic Drug Sales Market Forecast by Region
Table 75. Global Anti-Emetic Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Anti-Emetic Drug Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Anti-Emetic Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Anti-Emetic Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Anti-Emetic Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Anti-Emetic Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Anti-Emetic Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Anti-Emetic Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Anti-Emetic Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Anti-Emetic Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Anti-Emetic Drug Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Anti-Emetic Drug Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Anti-Emetic Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Anti-Emetic Drug Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Anti-Emetic Drug Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Anti-Emetic Drug Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Anti-Emetic Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Anti-Emetic Drug Revenue Market Share Forecast by Application (2023-2028)
Table 93. Merck Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Merck Anti-Emetic Drug Product Offered
Table 95. Merck Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Merck Main Business
Table 97. Merck Latest Developments
Table 98. Novartis Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Novartis Anti-Emetic Drug Product Offered
Table 100. Novartis Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Novartis Main Business
Table 102. Novartis Latest Developments
Table 103. Glenmark Pharmaceuticals Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Glenmark Pharmaceuticals Anti-Emetic Drug Product Offered
Table 105. Glenmark Pharmaceuticals Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Glenmark Pharmaceuticals Main Business
Table 107. Glenmark Pharmaceuticals Latest Developments
Table 108. F. Hoffmann-La Roche Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. F. Hoffmann-La Roche Anti-Emetic Drug Product Offered
Table 110. F. Hoffmann-La Roche Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. F. Hoffmann-La Roche Main Business
Table 112. F. Hoffmann-La Roche Latest Developments
Table 113. Heron Therapeutics Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Heron Therapeutics Anti-Emetic Drug Product Offered
Table 115. Heron Therapeutics Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Heron Therapeutics Main Business
Table 117. Heron Therapeutics Latest Developments
Table 118. Kyowa Kirin Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Kyowa Kirin Anti-Emetic Drug Product Offered
Table 120. Kyowa Kirin Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Kyowa Kirin Main Business
Table 122. Kyowa Kirin Latest Developments
Table 123. Aurobindo Pharma Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 124. Aurobindo Pharma Anti-Emetic Drug Product Offered
Table 125. Aurobindo Pharma Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Aurobindo Pharma Main Business
Table 127. Aurobindo Pharma Latest Developments
Table 128. Mylan Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 129. Mylan Anti-Emetic Drug Product Offered
Table 130. Mylan Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Mylan Main Business
Table 132. Mylan Latest Developments
Table 133. Hikma Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 134. Hikma Anti-Emetic Drug Product Offered
Table 135. Hikma Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Hikma Main Business
Table 137. Hikma Latest Developments
Table 138. Akorn Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 139. Akorn Anti-Emetic Drug Product Offered
Table 140. Akorn Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Akorn Main Business
Table 142. Akorn Latest Developments
Table 143. Dr. Reddy’s Laboratories Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 144. Dr. Reddy’s Laboratories Anti-Emetic Drug Product Offered
Table 145. Dr. Reddy’s Laboratories Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Dr. Reddy’s Laboratories Main Business
Table 147. Dr. Reddy’s Laboratories Latest Developments
Table 148. Cipla Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 149. Cipla Anti-Emetic Drug Product Offered
Table 150. Cipla Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Cipla Main Business
Table 152. Cipla Latest Developments
Table 153. Fresenius Kabi Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 154. Fresenius Kabi Anti-Emetic Drug Product Offered
Table 155. Fresenius Kabi Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. Fresenius Kabi Main Business
Table 157. Fresenius Kabi Latest Developments
Table 158. Wockhardt Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 159. Wockhardt Anti-Emetic Drug Product Offered
Table 160. Wockhardt Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 161. Wockhardt Main Business
Table 162. Wockhardt Latest Developments
Table 163. Sun Pharmaceutical Industries Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 164. Sun Pharmaceutical Industries Anti-Emetic Drug Product Offered
Table 165. Sun Pharmaceutical Industries Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 166. Sun Pharmaceutical Industries Main Business
Table 167. Sun Pharmaceutical Industries Latest Developments
Table 168. Teva Pharmaceutical Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 169. Teva Pharmaceutical Anti-Emetic Drug Product Offered
Table 170. Teva Pharmaceutical Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 171. Teva Pharmaceutical Main Business
Table 172. Teva Pharmaceutical Latest Developments
Table 173. Pfizer Basic Information, Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 174. Pfizer Anti-Emetic Drug Product Offered
Table 175. Pfizer Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 176. Pfizer Main Business
Table 177. Pfizer Latest Developments
List of Figures
Figure 1. Picture of Anti-Emetic Drug
Figure 2. Anti-Emetic Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Emetic Drug Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Anti-Emetic Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Anti-Emetic Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Injection
Figure 11. Product Picture of Others
Figure 12. Global Anti-Emetic Drug Sales Market Share by Type in 2021
Figure 13. Global Anti-Emetic Drug Revenue Market Share by Type (2017-2022)
Figure 14. Anti-Emetic Drug Consumed in Hospital
Figure 15. Global Anti-Emetic Drug Market: Hospital (2017-2022) & (K Units)
Figure 16. Anti-Emetic Drug Consumed in Clinic
Figure 17. Global Anti-Emetic Drug Market: Clinic (2017-2022) & (K Units)
Figure 18. Anti-Emetic Drug Consumed in Home Care
Figure 19. Global Anti-Emetic Drug Market: Home Care (2017-2022) & (K Units)
Figure 20. Anti-Emetic Drug Consumed in Others
Figure 21. Global Anti-Emetic Drug Market: Others (2017-2022) & (K Units)
Figure 22. Global Anti-Emetic Drug Sales Market Share by Application (2017-2022)
Figure 23. Global Anti-Emetic Drug Revenue Market Share by Application in 2021
Figure 24. Anti-Emetic Drug Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Anti-Emetic Drug Revenue Market Share by Company in 2021
Figure 26. Global Anti-Emetic Drug Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Anti-Emetic Drug Revenue Market Share by Geographic Region in 2021
Figure 28. Global Anti-Emetic Drug Sales Market Share by Region (2017-2022)
Figure 29. Global Anti-Emetic Drug Revenue Market Share by Country/Region in 2021
Figure 30. Americas Anti-Emetic Drug Sales 2017-2022 (K Units)
Figure 31. Americas Anti-Emetic Drug Revenue 2017-2022 ($ Millions)
Figure 32. APAC Anti-Emetic Drug Sales 2017-2022 (K Units)
Figure 33. APAC Anti-Emetic Drug Revenue 2017-2022 ($ Millions)
Figure 34. Europe Anti-Emetic Drug Sales 2017-2022 (K Units)
Figure 35. Europe Anti-Emetic Drug Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Anti-Emetic Drug Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa Anti-Emetic Drug Revenue 2017-2022 ($ Millions)
Figure 38. Americas Anti-Emetic Drug Sales Market Share by Country in 2021
Figure 39. Americas Anti-Emetic Drug Revenue Market Share by Country in 2021
Figure 40. United States Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Anti-Emetic Drug Sales Market Share by Region in 2021
Figure 45. APAC Anti-Emetic Drug Revenue Market Share by Regions in 2021
Figure 46. China Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Anti-Emetic Drug Sales Market Share by Country in 2021
Figure 53. Europe Anti-Emetic Drug Revenue Market Share by Country in 2021
Figure 54. Germany Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Anti-Emetic Drug Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Anti-Emetic Drug Revenue Market Share by Country in 2021
Figure 61. Egypt Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Anti-Emetic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Anti-Emetic Drug in 2021
Figure 67. Manufacturing Process Analysis of Anti-Emetic Drug
Figure 68. Industry Chain Structure of Anti-Emetic Drug
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...